China is in talks with Pfizer Inc (PFE.N) to secure a license that will allow domestic drug makers to manufacture and distribute a generic version of the U.S. firm’s COVID-19…
- info@stalliontimes.com
Tag:
We strive to publish high-quality news content and report stories/news that inform, educate, entertain, and hold leaders and institutions accountable while upholding the ethics of journalism to safeguard trust in news reportage.
Content does not represent the official opinion of Stallion Times unless specifically indicated.
© 2022 Stallion Times Media Services. All Right Reserved.